Your browser doesn't support javascript.
loading
Phase I study of a novel glioblastoma radiation therapy schedule exploiting cell-state plasticity.
Dean, Jamie A; Tanguturi, Shyam K; Cagney, Daniel; Shin, Kee-Young; Youssef, Gilbert; Aizer, Ayal; Rahman, Rifaquat; Hammoudeh, Lubna; Reardon, David; Lee, Eudocia; Dietrich, Jorg; Tamura, Kaoru; Aoyagi, Masaru; Wickersham, Lacey; Wen, Patrick Y; Catalano, Paul; Haas-Kogan, Daphne; Alexander, Brian M; Michor, Franziska.
Afiliación
  • Dean JA; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Tanguturi SK; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, Massachusetts, USA.
  • Cagney D; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
  • Shin KY; Department of Medical Physics and Biomedical Engineering, University College London, London, UK.
  • Youssef G; UCL Cancer Institute, University College London, London, UK.
  • Aizer A; Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
  • Rahman R; Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
  • Hammoudeh L; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Reardon D; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
  • Lee E; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
  • Dietrich J; Center for Neuro-Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Tamura K; Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
  • Aoyagi M; Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
  • Wickersham L; Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
  • Wen PY; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
  • Catalano P; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
  • Haas-Kogan D; Center for Neuro-Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Alexander BM; Department of Neurosurgery, Tokyo Medical and Dental University, Tokyo, Japan.
  • Michor F; Department of Neurosurgery, Tokyo Medical and Dental University, Tokyo, Japan.
Neuro Oncol ; 25(6): 1100-1112, 2023 06 02.
Article en En | MEDLINE | ID: mdl-36402744
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Glioblastoma Tipo de estudio: Guideline / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Neuro Oncol Asunto de la revista: NEOPLASIAS / NEUROLOGIA Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Glioblastoma Tipo de estudio: Guideline / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Neuro Oncol Asunto de la revista: NEOPLASIAS / NEUROLOGIA Año: 2023 Tipo del documento: Article